Value Investing Research & Market Analysis

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.015 +0.029 (+2.94%)
Delayed Quote Updated: 9:53 AM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms ↗
Inovio Pharmaceuticals (NASDAQ:INO) said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP ↗
Inovio Pharmaceuticals (NASDAQ:INO) is approaching an October 30 PDUFA date for INO-3107, its lead DNA medicine candidate for recurrent respiratory papillomatosis, or RRP, President and CEO Jacky Shea... 
Via MarketBeat
News headline image
Inovio (INO) Q2 2026 Earnings Call Transcript ↗
INO-3107 advances toward October FDA decision as company extends cash runway through early 2027. 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For November 10, 2025 ↗
 
Via Benzinga
News headline image
Earnings Outlook For Inovio Pharmaceuticals ↗
 
Via Benzinga
News headline image
Inovio Pharmaceuticals Q2 Earnings Call Highlights ↗
Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration has completed several key steps in its review of the company’s biologics license application for INO-3107, an... 
Via MarketBeat
Topics Earnings
Here are the top movers in Thursday's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗
Via Chartmill
News headline image
Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances ↗
Inovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Inovio (INO) Q1 2026 Earnings Call Transcript ↗
Inovio (INO) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? ↗
Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week. 
Via The Motley Fool
Topics Death
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
On Monday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Here are the top movers in Thursday's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-04-02: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
What's Behind The Drop In Inovio Pharmaceuticals Stock Today? ↗
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares are tumbling Thursday after the company announced the pricing of a proposed public offering. 
Via Benzinga
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
Discover the top movers in Thursday's pre-market session. ↗
Via Chartmill
News headline image
Inovio (INO) Q4 2025 Earnings Call Transcript ↗
Inovio (INO) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Inovio Stock Up On Earnings, Pipeline Progress ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher on Friday morning after the company reported fourth-quarter results. 
Via Benzinga
News headline image
Is Inovio Pharmaceuticals Stock Going to $0? ↗
This forgotten stock might be too risky even for contrarian investors. 
Via The Motley Fool
News headline image
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
The biopharmaceutical sector witnessed a dramatic surge in volatility today, December 29, 2025, as the industry careened toward the end of its strongest year in two decades. In a day defined by extreme... 
Via MarketMinute
Topics ETFs Intellectual Property
News headline image
Gapping stocks in Friday's session ↗
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Inovio Cuts Q2 Losses by 27% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
INOVIO PHARMACEUTICALS INC (NASDAQ:INO) Reports Q2 2025 Results: Revenue at $0.0, EPS Loss of $0.61 Amid 4.7% After-Hours Drop ↗
INOVIO reported Q2 2025 results with $0.0 revenue and a $0.61 EPS loss, meeting estimates. Shares fell 4.7% post-earnings amid pipeline uncertainty. Key focus remains on DNA medicine candidates like... 
Via Chartmill
News headline image
This Wingstop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2025 ↗
 
Via Benzinga
News headline image
Which stocks are moving after the closing bell on Friday? ↗
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.